Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...
Japanese golfer Akie Iwai shot a tournament-low 11-under-par 61 in Sunday's final round of the Honda LPGA Thailand to fin ...
We recently compiled a list of the 12 Best Japanese Stocks To Buy in 2025. In this article, we are going to take a look at ...
Takeda Healthcare Philippines, Inc. and Otsuka-Solar Philippines, Inc., with the support of the Embassy of Japan in the Ph ...
TOKYO, Jan 30 (Reuters) - Takeda Pharmaceutical (4502.T), opens new tab said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as ...
In line with the "We the UAE 2031" Vision, the summit focused on improving quality of life and advancing specialized care for Inflammatory Bowel Disease (IBD) ...
Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended December 31, 2024) showing ...
Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...
Zacks.com on MSN9d
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today. Takeda Pharmaceutical Co. (TAK) is a stock many investors are watching right ...
Explore AC Immune's innovative Alzheimer's and Parkinson's therapies, key pharma collaborations, and financial outlook. Learn more on ACIU stock here.
In the past week, a Boston biotech led by longtime industry CEO Harvey Berger said it plans to shut down, while another ...
The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results